✦ LIBER ✦

OnabotulinumtoxinA for chronic migraine treatment: 75% responder analysis from double-blind, randomized, placebo-controlled phase of PREEMPT

✍ Scribed by Dodick, D; Diener, HC; Turkel, C; DeGryse, R; Brin, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OnabotulinumtoxinA for treatment of chro

✍ Diener, H.; Dodick, D.; Aurora, S.; Turkel, C.; DeGryse, R.; Lipton, R.; Silbers 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

OnabotulinumtoxinA for treatment of chro

✍ Dodick, D.W.; Aurora, S.K.; Turkel, C.C.; DeGryse, R.E.; Silberstein, S.D.; Lipt 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

OnabotulinumtoxinA for Treatment of Chro

✍ David W. Dodick; Catherine C. Turkel; Ronald E. DeGryse; Sheena K. Aurora; Steph 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

Efficacy and Safety of Topiramate for th

✍ Stephen D. Silberstein; Richard B. Lipton; David W. Dodick; Frederick G. Freitag 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB

PSY3 A META-ANALYSIS OF RANDOMIZED, DOUB

✍ AJ Shuhendler; S Lee; M Siu; SL Ondovcik; K Lam; A Alabdullatif; X Zhang; M Mach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Dapoxetine for the Treatment of Prematur

✍ Shindel, A. 📂 Article 📅 2010 🏛 Elsevier Science ⚖ 50 KB